IL132081A0 - Fibrocyte-based cellular therapy formulations - Google Patents

Fibrocyte-based cellular therapy formulations

Info

Publication number
IL132081A0
IL132081A0 IL13208198A IL13208198A IL132081A0 IL 132081 A0 IL132081 A0 IL 132081A0 IL 13208198 A IL13208198 A IL 13208198A IL 13208198 A IL13208198 A IL 13208198A IL 132081 A0 IL132081 A0 IL 132081A0
Authority
IL
Israel
Prior art keywords
fibrocyte
based cellular
cellular therapy
therapy formulations
formulations
Prior art date
Application number
IL13208198A
Other languages
English (en)
Original Assignee
Picower Inst Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Picower Inst Med Res filed Critical Picower Inst Med Res
Publication of IL132081A0 publication Critical patent/IL132081A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13208198A 1997-03-28 1998-03-27 Fibrocyte-based cellular therapy formulations IL132081A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/828,415 US6759036B1 (en) 1997-03-28 1997-03-28 Fibrocyte-base vaccine formulations
PCT/US1998/006094 WO1998043482A1 (en) 1997-03-28 1998-03-27 Fibrocyte-based cellular therapy formulations

Publications (1)

Publication Number Publication Date
IL132081A0 true IL132081A0 (en) 2001-03-19

Family

ID=25251747

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13208198A IL132081A0 (en) 1997-03-28 1998-03-27 Fibrocyte-based cellular therapy formulations

Country Status (7)

Country Link
US (2) US6759036B1 (xx)
EP (1) EP0975225A4 (xx)
JP (1) JP2001518095A (xx)
AU (1) AU6782298A (xx)
CA (1) CA2284471A1 (xx)
IL (1) IL132081A0 (xx)
WO (1) WO1998043482A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030149246A1 (en) * 2002-02-01 2003-08-07 Russell John C. Macromolecular conjugates and processes for preparing the same
AU2007325029B2 (en) * 2006-11-30 2013-09-12 The Regents Of The University Of California Methods for treating and diagnosing fibrotic and fibroproliferative diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654186A (en) * 1993-02-26 1997-08-05 The Picower Institute For Medical Research Blood-borne mesenchymal cells
US5849307A (en) * 1997-03-26 1998-12-15 The Picower Institute For Medical Research Vaccine adjuvant

Also Published As

Publication number Publication date
AU6782298A (en) 1998-10-22
US20040022774A1 (en) 2004-02-05
WO1998043482A1 (en) 1998-10-08
US6759036B1 (en) 2004-07-06
JP2001518095A (ja) 2001-10-09
CA2284471A1 (en) 1998-10-08
EP0975225A1 (en) 2000-02-02
EP0975225A4 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
GB9715751D0 (en) Formulations
GB9708484D0 (en) Therapeutic agents
GB2323531B (en) Therapeutic formulations
GB9708945D0 (en) Therapeutic agents
GB9704948D0 (en) Therapeutic agents
ZA982368B (en) New therapeutic combinations
GB9702524D0 (en) Therapeutic agents
GB9700939D0 (en) Therapy
GB9700555D0 (en) Therapeutic agents
GB9723999D0 (en) Therapeutic use
IL132081A0 (en) Fibrocyte-based cellular therapy formulations
ZA982395B (en) Therapeutic composition
GB9726701D0 (en) Therapeutic use
GB9716463D0 (en) Therapeutic agents
GB9726702D0 (en) Therapeutic use
GB9709417D0 (en) Therapeutic formulations
GB9704885D0 (en) Therapy
GB9703101D0 (en) Formulations
GB9703099D0 (en) Formulations
GB9703100D0 (en) Formulations
GB9704521D0 (en) Formulations
GB9721266D0 (en) Therapeutic use
GB9721171D0 (en) Therapeutic use
GB9721194D0 (en) Therapeutic use
GB9726700D0 (en) Therapeutic use